Concepedia

Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions

Stacy Loeb, Qinlian Zhou, Uwe Siebert, Ursula Rochau, Beate Jahn, Nikolai Mühlberger, H. Ballentine Carter, Herbert Lepor, R. Scott Braithwaite

European Urology · 2017 · 34 citations · 45 references

DOI

Concepts

References

45

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci et al. · New England Journal of Medicine · 2015 · 2.8K citations · Full text

, , +15

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

Freddie C. Hamdy, Jenny Donovan, J. Athene Lane et al. · New England Journal of Medicine · 2016 · 2.6K citations · Full text

, , +13

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Nicholas D. James, Matthew R. Sydes, Noel W. Clarke et al. · The Lancet · 2015 · 2K citations · Full text

, , +17

Radical Prostatectomy versus Observation for Localized Prostate Cancer

Timothy J Wilt, Michael K. Brawer, Karen Jones et al. · New England Journal of Medicine · 2012 · 1.8K citations · Full text

, , +9

Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer

Mohummad Minhaj Siddiqui, Soroush Rais‐Bahrami, Barış Türkbey et al. · JAMA · 2015 · 1.5K citations · Full text

, , +17